Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Down 84.1% in March

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 2,200 shares, a decrease of 84.1% from the February 28th total of 13,800 shares. Based on an average daily volume of 29,700 shares, the days-to-cover ratio is currently 0.1 days.

Cardio Diagnostics Stock Down 17.9 %

Shares of CDIOW stock opened at $0.03 on Friday. Cardio Diagnostics has a one year low of $0.02 and a one year high of $0.18. The stock has a fifty day moving average price of $0.06 and a 200 day moving average price of $0.05.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.